327 event(s) found
Myeloma Week 2026 - Myeloma Management: Navigating Side Effects and Long-Term Care
Myeloma Management: Navigating Side Effects and Long-Term Care provides a clear, practical overview of myeloma, explaining what the disease is, how it is diagnosed, and why each person’s experience can differ. This webcast will walk participants through today’s treatment options—from initial therapies to newer and more advanced approaches now available. The session highlights what patients can typically expect at each stage of treatment, including how decisions are made and how care is tailored to individual needs. The presentation will also address common side effects, how they are managed, and what long-term care and monitoring can look like as myeloma often becomes a chronic condition. Attendees will leave with a better understanding of the treatment journey, the range of experiences patients may encounter, and the key questions to consider when navigating myeloma care.
4th AI for Oncology Conference / 1st Annual Meeting ESAC
The AI for Oncology Conference aims to equip participants with a comprehensive understanding of how advanced AI technologies are transforming cancer care and research. As AI innovation accelerates, its applications in oncology are becoming essential across the spectrum of diagnosis, treatment, and research. From integrating diverse datasets, such as multiomics, imaging, and clinical data, to advancing diagnostic precision, AI is enabling the discovery of patterns that traditional methods often overlook. We are proud to confirm the dates of the Society’s first Annual Meeting, co-organized by the Fondazione IRCCS Istituto Nazionale dei Tumori di Milano (www.istitutotumori.mi.it) which will take place on May 7th and 8th in Milan, in the Trifoglio building at the Politecnico di Milano. This marks an important milestone for ESAC, and the event will be synchronized with the 4th edition of the yearly AI for Oncology conference organized by Fondazione IRCCS Istituto Nazionale dei Tumori since 2023 (Scientific lead – A. Prelaj).
1st European Ovarian Cancer Research Symposium 2026 (OC-Insights)
It is a great pleasure for the University of Bergen's Centre for Cancer Biomarkers (CCBIO) to invite you to the 1st European Ovarian Cancer Research Symposium (OC-INSIGHTS). This year's title is "Improving ovarian cancer outcomes: harnessing tumor-host interactions". The 1st OC-INSIGHTS will be a combination of talks by invited international academic and other senior researchers, shorter presentations by PhD students and postdocs, extended poster sessions where younger researchers can present their work, and ample time for informal interaction between participants. Confirmed speakers include Usha Menon, Ronny Drapkin, Charlie Gourley, Susanna Banerjee, Olivia Le Saux, Sampsa Hautaniemi, Frances Balkwill, Krister Wennerberg, Denarda Dangaj, Anniina Färkkilä, Hanna Dahlstand, and Frederik Marmé, and many more. Sessions will include: Early detection/tumor initiation, Ethnic and histological diversity, Biomarkers and precision oncology, Preclinical modelling, Immunology and spatial biology, and Emerging cell types and targets. The 1st OC-INSIGHTS is part of our increasing focus on innovation and academic-industry interactions. Also, we allow industry participants to take part in our extended poster sessions with similarly sized stands among the academic exhibitors. The 1st OC-INSIGHTS is a satellite symposium to the 14th CCBIO Annual Symposium.
ASGCT 2026 Annual Meeting
Join us for ASGCT’s Annual Meeting in Boston and Online! As the largest and most comprehensive cell and gene therapy event, the Annual Meeting offers unique opportunities to explore the latest scientific research, stay abreast of new technologies, and forge career-advancing connections.
MEET2WIN - 11th Edition
Every year, the MEET2WIN convention brings together some 300 European players specifically involved in translational research and innovation in oncology in the broadest sense (researchers, clinicians, entrepreneurs, biotechs, pharmaceutical groups, investors, support structures, etc.) keen to expand their network of contacts and optimize their collaborations in the fight against cancer.
PSCC Petit déjeuner de l'écosystème - Closing the Gap in Liquid Biopsy: Comprehensive cfRNA Profiling within a 360° Epigenomics Approach
Don't miss the next Ecosystem Breakfast on the topic: Closing the Gap in Liquid Biopsy: Comprehensive cfRNA Profiling within a 360° Epigenomics Approach With: Matteo Tosolini and Jessica Apulei (Hologic Diagenode) Matteo Tosolini is a Biopharma Business Development Manager for EMEA at Hologic Diagenode with strong scientific background in epigenetics and marketing. He earned his PhD in Stem Cell Epigenetics in Université Paris-Saclay. He then joined Diagenode as Research Scientist first and then move into Marketing and Product Management. Jessica Apulei is Scientific Liaison Manager at Hologic Diagenode with strong expertise in epigenetics technologies and applications. She earned her PhD in Neurobiology and Epigenetics in Paris at the Collège de France and completed her postdoctoral research in Boston at Harvard University. Her work focuses on advancing cfDNA and epigenomic technologies to support biomarker discovery, translational research, and precision medicine.
51st Annual ONS Congress®
Join thousands of colleagues embracing new discoveries while keeping patient care at the forefront. ONS Congress® is the largest, most comprehensive conference dedicated to oncology nursing.
ESTRO 2026
ESTRO 2026 will take place in Stockholm, Sweden from 15 to 19 May and introduce this year’s congress theme: “Innovating Radiation Oncology, Together”. ESTRO 2025 focused on transformative innovation through partnership, via collaboration within our Radiation Oncology Community and especially with our scientific friends and partners from basic science, translational research and multidisciplinary cancer care. This journey will be continued, aiming to stay at the forefront of innovation. ESTRO 2026 will broach the opportunities to innovate our discipline itself, to optimally prepare us for tomorrow’s clinical, professional and scientific changes and challenges. The theme will be reflected throughout the programme. Exciting keynote speakers will surprise us, more patients than ever will provide their perspectives and reflections, and interaction between chairs, speakers and the participants will be further increased, to maximise the learning experience. The joint call for abstracts with the Lancet Oncology will be continued. We will acknowledge scientific excellence, not only by awarding a select few individuals but also the TOP 5% of all abstracts. Our communication of breakthrough science via social channels and the press will be boosted, both during and after the congress. These measures will make ESTRO 2026 THE meeting to showcase and learn from TOP practice-changing clinical trials and breakthrough research in all fields of Radiation Oncology. ESTRO 2026 will be in vibrant Stockholm for the first time, an exciting Scandinavian city which is not only the capital of Sweden, but the home of many Radiation Oncology companies. Stockholm is famous for its sustainability and its Scandinavian efficiency. Stockholm will host the beloved ESTRO 5K run, and our famous Monday night ESTRO party! ESTRO 2026 will host Europe’s largest industry exhibition in Radiation Oncology, offering you a unique opportunity to interact with industry leaders and to find out about their latest innovations. Join the ever-growing ESTRO family in Stockholm.
The Evolving Landscape of Advanced Prostate Cancer Treatment: A Guidelines and Case-Based Discussion
As part of AUA 2026, "The Evolving Landscape of Advanced Prostate Cancer Treatment" is a complimentary, comprehensive, guidelines-driven and case-based program designed to equip clinicians with up-to-date strategies for managing complex disease states across the prostate cancer continuum. Faculty will explore multidisciplinary care models, genetic testing, next-generation imaging and theranostics. Case-based discussions will provide practical guidance on treatment selection and sequencing for hormone-sensitive and castration-resistant prostate cancer—including M0 and M1 disease—as well as precision medicine and emerging therapeutic options. Participants will leave with actionable insights to optimize individualized care in an increasingly sophisticated therapeutic landscape.
SINTOMA 2026: 9th International Symposium on Hematology-Oncology
Join us at the main onco-hematology event in Brazil and learn about the most relevant and recent advances in this specialty. SINTOMA brings together some of the greatest hematologists in Brazil and the world in a unique experience of scientific updating. For three days, you will have access to the latest research, debates on challenging clinical cases and international trends, all designed to enhance your clinical practice.
16th International Symposium of the Japanese Society of Hematology
The theme of this symposium is “Stem Cells and Beyond”, reflecting the Japanese Society of Hematology's (JSH) focus on the biology of hematopoietic stem cells, malignant stem cells of hematologic tumors, stem cell-based therapies, and hematopoietic stem cell transplantation. This symposium will bring together leading scientists and clinicians from around the world to exchange the latest knowledge and discuss future directions in stem cell-based hematology. We have exciting sessions such as on HSC biology, clonal hematopoiesis, leukemia stem cells, aging and inflammation, iPSC-derived cell therapy and stem cell transplantation. Thanks to a long-standing friendship and collaboration with ASH and EHA, we have joint sessions on next generation cell therapy and HSC dynamics.
Cancer Research into Action
To close its wonderful 60th anniversary year, IARC will offer you the opportunity to register for a major scientific conference that will take place over three days, from 19 to 21 May 2026. This conference will bring together experts from around the world and will be held at IARC and la Halle Tony Garnier.
VII Congresso Brasileiro de Hematologia Laboratorial (CBHL 2026)
In Portuguese: "O CBHL tem se consolidado como um dos principais encontros nacionais voltados à hematologia laboratorial. Nesta edição, haverá a participação de renomados palestrantes nacionais, cujas trajetórias acadêmicas e profissionais contribuem significativamente para o avanço da hematologia no Brasil. Evento gratuito para associados da ABHH. Target Audience: Profissionais de diversas áreas, incluindo médicos hematologistas, biomédicos, farmacêuticos, biólogos e analistas clínicos."
FDA Workshop: Contemporary Issues in Non-Muscle Invasive Bladder Cancer (NMIBC) Trial Design and Interpretation
The FDA Oncology Center of Excellence is convening a workshop to explore critical issues in NMIBC trial design and interpretation. This session will bring together perspectives from molecular biology, clinical pathology, urology, and medical oncology to examine key scientific and clinical considerations. Key discussion topics: · Similarities and differences between papillary and carcinoma in situ histology in NMIBC—and their implications for demonstrating efficacy in clinical trials. · The current Bacillus Calmette-Guérin (BCG) shortage and its impact on clinical trial design.
Soirée régionale Cas Cliniques maladies rares immuno-hématologiques « PACA-Corse »
In French: "Les centres de référence et de compétence maladies rares de la région vous invite à assister à une soirée de cas cliniques, présentés par les internes de leur service. Un vote sera fait en fin de soirée et l’interne du meilleur cas clinique gagnera une prise en charge au congrès européen de son choix. Inscription : gratuite mais obligatoire, uniquement pour les médecins et internes de la région PACA Corse, en complétant le formulaire ci-dessous. Déplacements (train et hôtel si besoin) pris en charge directement par la filière MaRIH sur demande via le formulaire (pas de remboursements possibles)."
2nd SIGN'IT Symposium - Signatures in Cancer Immunotherapy
Fondation ARC is proud to organize the 2nd SIGN’IT Symposium – Signatures in Cancer Immunotherapy, to be held on May 20th 2026 in Paris. This high-level scientific event will bring together SIGN’IT grant recipients and leaders in the field to present and discuss the latest advances arising from the funded projects. Designed as a forum for scientific exchange and interdisciplinary dialogue, the symposium will highlight emerging concepts, innovative methodologies, and translational breakthroughs in immunotherapy research. The symposium is open to the national and international scientific and medical community engaged in cancer immunotherapy, and aims to foster collaborations, stimulate innovation, and accelerate the translation of biomarker research into clinical practice.
Utiliser l’I.A. pour la recherche sur le cancer : Que peut-on faire en pratique ?
In French: "Cette journée d’étude, dédiée aux liens entre intelligence artificielle et recherche en cancérologie, a pour objectif de sensibiliser et d’acculturer les chercheurs et chercheuses aux usages de l’IA dans leurs pratiques scientifiques. Elle vise à réunir des acteurs et actrices issus de différentes disciplines – biologistes, clinicien·nes, chercheur·ses en informatique et en science des données – afin d’échanger autour des apports de l’intelligence artificielle dans la recherche sur le cancer, mais aussi de ses limites et des questions qu’elle soulève. Le programme ambitionne ainsi de démystifier l’intelligence artificielle, d’illustrer ses usages actuels en cancérologie à travers des exemples concrets, et d’encourager une réflexion collective sur les enjeux scientifiques, éthiques et sociétaux associés à ces outils."
6th SUNRiSE Meeting
6th SUNRiSE Meeting organized by SUNRiSE Network
Antibody Engineering & Therapeutics Europe
Where Antibody, Protein and ADC Innovation is Driven to Commercial Success! Europe's Leading Antibody Event for Discovery, Engineering and Therapeutic Development in Neurodegeneration, Metabolism, Autoimmunity & Much More.
54 reunión anual PETHEMA
Latest edition of PETHEMA's annual meeting, held in Spanish. More information coming soon…
ASCO® Annual Meeting 2026
The ASCO Annual Meeting is more than a conference—it’s the place to be a part of something bigger. This is where groundbreaking science, innovation, and connection come together to shape the future of cancer care.
Clinical Ethics: End-of-Life Care
Clinical Ethics: End-of-Life Care organized by Deakin Bioethics (Deakin University)
BC Cancer - Lymphoma Patient Education Forum
Lymphoma Matters: Knowledge, Care, and Connection Join us for a day of learning and connection hosted by BC Cancer experts. We’ll cover lymphoma basics to the latest research and new treatments like immune, cellular, bispecific antibody therapies. You’ll also have the chance to join smaller groups focused on specific types of lymphoma (NHL, HL, CLL) and attend sessions on nutrition, mental health, and patient stories.
Fórum de Acesso e Equidade da ABHH (Região Centro-Oeste)
In Portuguese: "O Fórum de Acesso e Equidade da ABHH – Região Centro-Oeste reunirá especialistas, profissionais de saúde e representantes da sociedade para debater os desafios e avanços relacionados ao acesso e à equidade em hematologia e hemoterapia. O evento busca promover diálogo, compartilhar experiências regionais e construir propostas que fortaleçam políticas públicas voltadas para a melhoria da assistência aos pacientes. Será uma oportunidade única de integração e reflexão sobre caminhos para garantir mais justiça e qualidade no cuidado em saúde. Inscrições serão abertas em breve."